The 24,000-square-foot facility located within a mile of the company’s early-phase oral drug product center of excellence, has been established to support clinical studies in phases 1-3. The site offers end-to-end services including supply management, primary and secondary packaging and labeling, storage, distribution, returns and destruction.

“Our new full-service San Diego supply facility is strategically located to work in tandem with our development center and serve customers not only on the West Coast of the U.S. and Canada, but across the world,” commented Kristen DeVito, Vice President of Operations, Clinical Supply Services, North America at Catalent. “In addition to investments we have made across our global network, the site is part of a wider strategy to provide local, integrated supply services, which offer a supply chain advantage as the world adjusts to the impact of the pandemic and its inherent logistical challenges.”

With a network spanning the U.S., U.K., Germany, Singapore, Japan and China, and over 50 additional global depots, Catalent’s clinical supply services can handle a broad range of international compliance and distribution requirements to support global clinical trials.

For further information on Catalent’s Clinical Supply Services business visit https://www.clinical.catalent.com.